 |
|
|
|
|
|
|
Important Notice: The ADDF/ISOA and Alzheimer Research Forum do not endorse any company or product, and listing in this directory is not linked to corporate sponsorship. We do not make a claim to being comprehensive or up to date. If you would like to recommend a company to be listed in the database, please contact us.
|
|
|
 |
|
|
|
|
|
|
Amorfix Life Sciences Ltd.
Website: http://www.amorfix.com/
Company/Resource Category: Proteins/Enzymes, Discovery, Development
Profile:
Amorfix Life Sciences focuses on the detection of aggregated misfolded
proteins and has developed a highly sensitive and quantitative assay
that detects aggregated Aβ in AD mouse models younger than three months old, and long before the deposition and appearance of plaques. This
assay, called the A4 test, could be an effective tool for quantifying
the efficacy of AD therapeutic candidates in animal models early in
disease progression and may shorten the duration of preclinical animal
trials.
|
|
|
|
|
Home
